Citations

Clear

124 citation(s) found for "Storm, A".

S143 Trends and Impact of EUS Utilization for Pancreatic Cysts Over Time
Wang, Lillian , Vatsavayi, Priyanka , Gleeson, Ferga C. , Umar, Shifa , Velaga, Saran Teja , Rajan, Elizabeth , Dayyeh, Barham Abu, Vege, Santhi Swaroop , Majumder, Shounak , Storm, Andrew C. , Chandrasekhara, Vinay

Mayo Clinic

American Journal of Gastroenterology | October 18, 2023 | Volume: 118 | Issue: 10S | Pages: S111-S111

10.14309/01.ajg.0000950212.87189.4d Get It

S1231 Predictors of Successful Stone Fragmentation and Extraction Using Electrohydraulic Lithotripsy: A Multicentric Study
Sayegh, Lea N. , Akiki, Karl, Salame, Marita , Annan, Karim Al , Winkie, Mason, Kolachana, Sindhura, Yohannan, Ethan David, Marya, Neil B. , Pawa, Swati , Kim, Raymond , Akiki, Karl, Fadel, Anthony , Achebe, Ikechukwu , Canakis, Andrew , Marya, Neil B. , Pawa, Rishi , Storm, Andrew C.

Mayo Clinic

American Journal of Gastroenterology | October 18, 2023 | Volume: 118 | Issue: 10S | Pages: S940-S941

10.14309/01.ajg.0000954564.56753.77 Get It

S1655 Weight Loss Outcomes of Endoscopic Sleeve Gastroplasty Across Age Groups
Gala, Khushboo , Brunaldi, Vitor , McGowan, Christopher , Maselli, Daniel B. , Sharaiha, Reem Z. , Wilson, Erik B., VanderWel, Brandon , Ujiki, Michael , Kedia, Prashant , Dayyeh, Barham Abu, Vargas, Eric J. , Acosta, Andrés , Storm, Andrew C.

Mayo Clinic

American Journal of Gastroenterology | October 18, 2023 | Volume: 118 | Issue: 10S | Pages: S1238-S1239

10.14309/01.ajg.0000956260.54523.2b Get It

S794 Effectiveness of Somatostatin Analogues for Gastrointestinal Angiodysplasia in Patients on Anticoagulation Therapy for Atrial Fibrillation: A Propensity Matched Study
Starkey, Morgan R., Kochhar, Gursimran , Singh, Achintya Dinesh , Desai, Aakash , Storm, Andrew C.

Mayo Clinic

American Journal of Gastroenterology | October 18, 2023 | Volume: 118 | Issue: 10S | Pages: S582-S582

10.14309/01.ajg.0000952816.50588.42 Get It

Correction to: Endoscopic Ultrasound-Guided Gastrojejunostomy for Superior Mesenteric Artery Syndrome Secondary to Rapid Weight Loss
Alqaisieh, Mohammad , Mahmoud, Tala , Akiki, Karl, Law, Ryan , Law, Ryan J, Storm, Andrew C.

Mayo Clinic

ACG Case Reports Journal | October 11, 2023 | Volume: 9 | Issue: 11 | Pages: e00914

10.14309/crj.0000000000000914 | PMID 36397884 Get It

Performance of Endoscopic Sleeve Gastroplasty by Obesity Class in the United States Clinical Setting
Gala, Khushboo, Brunaldi, Vitor , McGowan, Christopher , Sharaiha, Reem Z. , Maselli, Daniel B. , VanderWel, Brandon , Kedia, Prashant , Ujiki, Michael , Wilson, Eric P., Gala, Khushboo , Wilson, Eric, Vargas, Eric J. , Storm, Andrew C. , Dayyeh, Barham K. Abu

Mayo Clinic

Clinical and Translational Gastroenterology | October 3, 2023 | Volume: 15 | Issue: 1 | Pages: e00647

10.14309/ctg.0000000000000647 | PMID 37787450 Get It

INTRODUCTION: Endoscopic sleeve gastroplasty (ESG) has gained popularity over the past decade and has been adopted in both academic and private institutions globally. We present outcomes of the largest cohort of patients from the United States undergoing ESG and evaluate these according to obesity class. METHODS: We performed a retrospective analysis of adult patients who underwent ESG. Medical information was abstracted from the electronic record with weight records up to 2 years after ESG. Percent total body weight loss (%TBWL) at 6, 12, 18, and 24 months was calculated based on baseline weight at the procedure. SPSS (version 29.0) was used for all statistical analyses. RESULTS: A total of 1,506 patients from 7 sites were included (501 Class I obesity, 546 Class II, and 459 Class III). Baseline demographics differed according to obesity class due to differences in age, body mass index (BMI), height, sex distribution, and race. As early as 6 months post-ESG, mean BMI for each class dropped to the next lower class and remained there through 2 years. %TWBL achieved in the Class III group was significantly greater when compared with other classes at all time points. At 12 months, 83.2% and 60.9% of patients had ≥10% and ≥15% TBWL for all classes. There were no differences in adverse events between classes. DISCUSSION: Real-world data from a large cohort of patients of all BMI classes across the United States shows significant and sustained weight loss with ESG. ESG is safe to perform in a higher obesity class with acceptable midterm efficacy.
Endotheliitis and cytokine storm as a mechanism of clot formation in COVID-19 ischemic stroke patients: A histopathologic study of retrieved clots
Brinjikji, Waleed , Kallmes, David F. , Humphries, William, Zaidat, Osama O. , Jones, Jesse , Siddiqui, Adnan H. , Douglas, Andrew , Rossi, Rosanna , Rentzos, Alexander, Ceder, Erik , Carlqvist, Jeanette , Dunker, Dennis, Doyle, Karen , Jones, Jesse , Rossi, Rosanna , Doyle, Karen M , Siddiqui, Adnan H , Virmani, Renu , De Meyer, Simon F , Yoo, Albert J. , Teleb, Mohamed , Andersson, Tommy , Nogueira, Raul G. , Gil, Sara Molina, Rentzos, Alexander, Jood, Katarina , Tatlisumak, Turgut

Mayo Clinic

Interventional Neuroradiology | September 28, 2023 | Volume: 31 | Issue: 5 | Pages: 660-665

10.1177/15910199231185804 | PMID 37769315 Get It

Background Studies during the COVID-19 pandemic have demonstrated an association between COVID-19 virus infection and the development of acute ischemic stroke, particularly large vessel occlusion (LVO). Studying the characteristics and immunohistochemistry of retrieved stroke emboli during mechanical thrombectomy for LVO may offer insights into the pathogenesis of LVO in COVID-19 patients. We examined retrieved COVID-19 emboli from the STRIP, EXCELLENT, and RESTORE registries and compared their characteristics to a control group. Methods We identified COVID-positive LVO patients from the STRIP, RESTORE, and EXCELLENT studies who underwent mechanical thrombectomy. These patients were matched to a control group controlling for stroke etiology based on Trial of Org 10172 in Acute Stroke Treatment criteria. All clots were stained with Martius Scarlet Blue (MSB) along with immunohistochemistry for interleukin-6 (IL-6), C-reactive protein (CRP), von Willebrand factor (vWF), CD66b, fibrinogen, and citrullinated Histone H3. Clot composition was compared between groups. Results Nineteen COVID-19-positive patients and 38 controls were included. COVID-19-positive patients had a significantly higher percentage of CRP and vWF. There was no difference in IL-6, fibrin, CD66b, or citrullinated Histone H3 between groups. Based on MSB staining, there was no statistically significant difference regarding the percentage of red blood cells, white blood cells, fibrin, and platelets. Conclusions Our study found higher concentrations of CRP and vWF in retrieved clots of COVID-19-positive stroke patients compared to COVID-19-negative controls. These findings support the potential role of systemic inflammation as indicated by elevated CRP and endothelial injury as indicated by elevated vWF as precipitating factors in thrombus development in these patients.
Risk of post-sphincterotomy bleeding in patients with thrombocytopenia
AbiMansour, Jad P. , Garimella, Vishal, Petersen, Bret T. , Law, Ryan , Martin, John A. , Levy, Michael J. , Law, Ryan J, AbiMansour, Jad , Petersen, Bret T. , Storm, Andrew C. , Dayyeh, Barham K. Abu , Chandrasekhara, Vinay

Mayo Clinic

Therapeutic Advances in Gastrointestinal Endoscopy | September 25, 2023 | Volume: 16 | Issue: No issue available | Pages: No page available

10.1177/26317745231200971 | PMID 37767287 Get It

Background: Reports suggest that the rate of adverse events (AEs) post-endoscopic sphincterotomy (ES) to be as high as 10%, with gastrointestinal bleeding being most common after post-endoscopic retrograde cholangiopancreatography (ERCP) pancreatitis. Objective: The aim of this study was to characterize the incidence of bleeding in patients with thrombocytopenia following ES. Design: Retrospective observational cohort study. Methods: Patients with thrombocytopenia (defined as <150,000 platelets/μL) who underwent ES between May 2017 and December 2020 were identified at a tertiary care medical center. The incidence of immediate (intraprocedural oozing >5 min or requiring intervention) or delayed (clinical bleeding with associated hemoglobin drop within 14 days) post-ES bleeding was determined via manual chart review. Results: A total of 221 patients with a mean platelet count of 108,000 ± 13,000 platelets/μL underwent ERCP with ES. Immediate bleeding occurred in 11 (5%) patients with no significant drop in hemoglobin or transfusion requirement. Two patients (0.9%), both of whom were noted to have immediate bleeding, also developed delayed bleeding. Presence of malignancy was associated with an increased risk of bleeding (36.4% versus 11.4%, p = 0.037) while platelet count was not. Conclusion: In a cohort of patients with thrombocytopenia, rates of immediate and delayed bleeding are similar to previously reported AE rates of ES in the general patient population. Careful attention should be given to patients with a history of active malignancy as well as those who develop immediate bleeding as they appear to be at increased risk for bleeding complications.
Cytokine Storm Due to Intralesional Intelukin-2 Therapy for Cutaneous In-Transit Melanoma
Isaq, Nasro , Brewer, Jerry D., Montane, Heather, Demer, Addison M. , Isaq, Nasro A., Brewer, Jerry, Markovic, Svetomir N.

Mayo Clinic

Dermatologic Surgery | September 5, 2023 | Volume: 49 | Issue: 12 | Pages: 1198-1199

10.1097/dss.0000000000003930 | PMID 37669243 Get It

Predictive factors for decreased baseline quality of life in patients with sinonasal malignancies
Fleseriu, Cara M. , Beswick, Daniel M. , Maoz, Sabrina L. , Hwang, Peter H. , Chan, Erik, Adappa, Nithin D. , Getz, Anne E., Humphries, Ian M., Chang, Eugene H. , Jafari, Aria , Kingdom, Todd T. , Kohanski, Michael A. , Lee, Jivianne K., Nabavizadeh, Seyed Ali , Adappa, Nithin D. , Patel, Zara M. , Smith, Timothy L. , Storm, Jay, Wang, Marilene B. , Choby, Garret , Kuan, Edward C , Humphreys, Ian M , Jafari, Aria , Nayak, Jayakar V , Patel, Zara , Smith, Timothy L , Snyderman, Carl H , Wang, Eric W , Beswick, Daniel , Hwang, Peter H , Maoz, Sabrina L , Choby, Garret , Adappa, Nithin D. , Geltzeiler, Mathew , Humphreys, Ian M. , Le, Christopher H. , Abuzeid, Waleed M. , Lee, Jivianne K., Nayak, Jayakar V. , Pinheiro‐Neto, Carlos , Resnick, Adam , John, Maie A. St. , Suh, Jeffrey D.

Mayo Clinic

International Forum of Allergy & Rhinology | August 30, 2023 | Volume: 14 | Issue: 4 | Pages: 775-785

10.1002/alr.23261 | PMID 37646428 Get It

AbstractBackgroundThe impact of sinonasal malignancies (SNMs) on quality of life (QOL) at presentation is poorly understood. The Sinonasal Outcome Test (SNOT‐22) and University of Washington Quality of Life (UWQOL) are validated QOL instruments with distinctive subdomains. This study aims to identify factors impacting pretreatment QOL in SNM patients to personalize multidisciplinary management and counseling.MethodsPatients with previously untreated SNMs were prospectively enrolled (2015–2022) in a multicenter observational study. Baseline pretreatment QOL instruments (SNOT‐22, UWQOL) were obtained along with demographics, comorbidities, histopathology/staging, tumor involvement, and symptoms. Multivariable regression models identified factors associated with reduced baseline QOL.ResultsAmong 204 patients, presenting baseline QOL was significantly reduced. Multivariable regression showed worse total SNOT‐22 QOL in patients with skull base erosion (p = 0.02). SNOT‐rhinologic QOL was worse in women (p = 0.009), patients with epistaxis (p = 0.036), and industrial exposure (p = 0.005). SNOT extranasal QOL was worse in patients with industrial exposure (p = 0.016); worse SNOT ear/facial QOL if perineural invasion (PNI) (p = 0.027). Squamous cell carcinoma pathology (p = 0.037), palate involvement (p = 0.012), and pain (p = 0.017) were associated with worse SNOT sleep QOL scores. SNOT psychological subdomain scores were significantly worse in patients with palate lesions (p = 0.022), skull base erosion (p = 0.025), and T1 staging (p = 0.023). Low QOL was more likely in the presence of PNI on UW health (p = 0.019) and orbital erosion on UW overall (p = 0.03). UW social QOL was worse if palatal involvement (p = 0.023) or PNI (p = 0.005).ConclusionsOur findings demonstrate a negative impact on baseline QOL in patients with SNMs and suggest sex‐specific and symptom‐related lower QOL scores, with minimal histopathology association. Anatomical tumor involvement may be more reflective of QOL than T‐staging, as orbital and skull base erosion, PNI, and palate lesions are significantly associated with reduced baseline QOL.